XPhyto Therapeutics Corp.
XPhyto Therapeutics Corp. 4XT.DE Peers
See (4XT.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 4XT.DE | $0.37 | N/A | N/A | -2.18 | -$0.17 | N/A |
| ZOE.DE | $141.98 | -1.25% | 63.21B | 28.62 | $4.96 | +1.10% |
| MRK.DE | $114.30 | -2.93% | 49.61B | 17.64 | $6.48 | +1.92% |
| DMP.DE | $35.20 | +0.43% | 1.90B | 18.33 | $1.92 | +2.50% |
| EVT.DE | $7.04 | -1.07% | 1.25B | -6.02 | -$1.17 | N/A |
| 2HQ.DE | $0.38 | -12.97% | 387.34M | -0.39 | -$0.97 | N/A |
| PSG.DE | $26.40 | -1.49% | 303.93M | 16.82 | $1.57 | +5.15% |
| HAEK.DE | $21.40 | -1.83% | 111.50M | 11.57 | $1.85 | N/A |
| 93M1.DE | $25.60 | +0.39% | 109.60M | 0.92 | $27.90 | +4.69% |
| APPH.DE | $11.25 | -0.44% | 93.71M | 125.00 | $0.09 | N/A |
Stock Comparison
4XT.DE vs ZOE.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, ZOE.DE has a market cap of 63.21B. Regarding current trading prices, 4XT.DE is priced at $0.37, while ZOE.DE trades at $141.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas ZOE.DE's P/E ratio is 28.62. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to ZOE.DE's ROE of +0.51%. Regarding short-term risk, 4XT.DE is less volatile compared to ZOE.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs MRK.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, MRK.DE has a market cap of 49.61B. Regarding current trading prices, 4XT.DE is priced at $0.37, while MRK.DE trades at $114.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas MRK.DE's P/E ratio is 17.64. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to MRK.DE's ROE of +0.10%. Regarding short-term risk, 4XT.DE is less volatile compared to MRK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs DMP.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, DMP.DE has a market cap of 1.90B. Regarding current trading prices, 4XT.DE is priced at $0.37, while DMP.DE trades at $35.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas DMP.DE's P/E ratio is 18.33. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to DMP.DE's ROE of +0.20%. Regarding short-term risk, 4XT.DE is less volatile compared to DMP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs EVT.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, EVT.DE has a market cap of 1.25B. Regarding current trading prices, 4XT.DE is priced at $0.37, while EVT.DE trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas EVT.DE's P/E ratio is -6.02. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to EVT.DE's ROE of -0.22%. Regarding short-term risk, 4XT.DE is less volatile compared to EVT.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs 2HQ.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, 2HQ.DE has a market cap of 387.34M. Regarding current trading prices, 4XT.DE is priced at $0.37, while 2HQ.DE trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas 2HQ.DE's P/E ratio is -0.39. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to 2HQ.DE's ROE of -0.29%. Regarding short-term risk, 4XT.DE is less volatile compared to 2HQ.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs PSG.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, PSG.DE has a market cap of 303.93M. Regarding current trading prices, 4XT.DE is priced at $0.37, while PSG.DE trades at $26.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas PSG.DE's P/E ratio is 16.82. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to PSG.DE's ROE of +0.49%. Regarding short-term risk, 4XT.DE is less volatile compared to PSG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs HAEK.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, HAEK.DE has a market cap of 111.50M. Regarding current trading prices, 4XT.DE is priced at $0.37, while HAEK.DE trades at $21.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas HAEK.DE's P/E ratio is 11.57. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to HAEK.DE's ROE of +0.06%. Regarding short-term risk, 4XT.DE is less volatile compared to HAEK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs 93M1.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, 93M1.DE has a market cap of 109.60M. Regarding current trading prices, 4XT.DE is priced at $0.37, while 93M1.DE trades at $25.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas 93M1.DE's P/E ratio is 0.92. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to 93M1.DE's ROE of +0.41%. Regarding short-term risk, 4XT.DE is less volatile compared to 93M1.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs APPH.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, APPH.DE has a market cap of 93.71M. Regarding current trading prices, 4XT.DE is priced at $0.37, while APPH.DE trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas APPH.DE's P/E ratio is 125.00. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to APPH.DE's ROE of +0.02%. Regarding short-term risk, 4XT.DE and APPH.DE have similar daily volatility (0.00).
4XT.DE vs B8F.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, B8F.DE has a market cap of 20.67M. Regarding current trading prices, 4XT.DE is priced at $0.37, while B8F.DE trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas B8F.DE's P/E ratio is -32.40. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to B8F.DE's ROE of +0.17%. Regarding short-term risk, 4XT.DE is less volatile compared to B8F.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs 21P1.F Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, 21P1.F has a market cap of 19.64M. Regarding current trading prices, 4XT.DE is priced at $0.37, while 21P1.F trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas 21P1.F's P/E ratio is -0.01. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to 21P1.F's ROE of -0.06%. Regarding short-term risk, 4XT.DE is less volatile compared to 21P1.F. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs SBX.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, SBX.DE has a market cap of 17.81M. Regarding current trading prices, 4XT.DE is priced at $0.37, while SBX.DE trades at $3.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas SBX.DE's P/E ratio is -1.42. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to SBX.DE's ROE of -0.55%. Regarding short-term risk, 4XT.DE is less volatile compared to SBX.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs HOB0.F Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, HOB0.F has a market cap of 17.00M. Regarding current trading prices, 4XT.DE is priced at $0.37, while HOB0.F trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas HOB0.F's P/E ratio is 6.30. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to HOB0.F's ROE of -1.18%. Regarding short-term risk, 4XT.DE and HOB0.F have similar daily volatility (0.00).
4XT.DE vs Z6A.F Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, Z6A.F has a market cap of 4.52M. Regarding current trading prices, 4XT.DE is priced at $0.37, while Z6A.F trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas Z6A.F's P/E ratio is -0.02. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to Z6A.F's ROE of -0.23%. Regarding short-term risk, 4XT.DE is less volatile compared to Z6A.F. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs PA8.DE Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, PA8.DE has a market cap of 2.71M. Regarding current trading prices, 4XT.DE is priced at $0.37, while PA8.DE trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas PA8.DE's P/E ratio is -0.13. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to PA8.DE's ROE of -0.09%. Regarding short-term risk, 4XT.DE is less volatile compared to PA8.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs 2NU.F Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, 2NU.F has a market cap of 1.08M. Regarding current trading prices, 4XT.DE is priced at $0.37, while 2NU.F trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas 2NU.F's P/E ratio is -0.03. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to 2NU.F's ROE of N/A. Regarding short-term risk, 4XT.DE is less volatile compared to 2NU.F. This indicates potentially lower risk in terms of short-term price fluctuations for 4XT.DE.
4XT.DE vs ERV2.F Comparison
4XT.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4XT.DE stands at N/A. In comparison, ERV2.F has a market cap of 312901.00. Regarding current trading prices, 4XT.DE is priced at $0.37, while ERV2.F trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4XT.DE currently has a P/E ratio of -2.18, whereas ERV2.F's P/E ratio is -0.02. In terms of profitability, 4XT.DE's ROE is -7.27%, compared to ERV2.F's ROE of +2.97%. Regarding short-term risk, 4XT.DE and ERV2.F have similar daily volatility (0.00).